Ivacaftor impacts nutrition and growth status in 4 to 24 month old children within the first 12 weeks
Successful treatment of a blockage in the lower portion of the small intestine in patients with cystic fibrosis using a solution administered during a colonoscopy.
Weight A Minute: Exploring the effect on total weight, fat and fat-free weight after the initiation of Elexacaftor/ Tezacaftor/ Ivacaftor in adults with CF
People with CF face high costs of CF care which have implications for debt, access to health care, adequate food, and other necessities of life.
What happens to muscle, fat and body mass index between 8 and 18 years of age in children with cystic fibrosis
Elexacaftor/Tezacaftor/Ivacaftor improves CFTR activity and pulmonary function in Cystic Fibrosis Patients carrying the N1303K Mutation
